Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10Pancreatic Neoplasms 9Neoplasm Metastasis 5Breast Neoplasms 5Melanoma 4Colorectal Neoplasms 4Prostatic Neoplasms 3Ovarian Neoplasms 3Lymphoma 3Lung Neoplasms 3Liver Neoplasms 3Carcinoma, Renal Cell 3Wilms Tumor 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Neuroblastoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Kidney Neoplasms 2Astrocytoma 2Adenomatous Polyposis Coli 2Thyroid Neoplasms 1Thrombocytosis 1Somatostatinoma 1Sarcoma, Clear Cell 1Retinoblastoma 1

Interventions

temsirolimus 1dehydroftorafur 1Vincristine 1Sirolimus 1Razoxane 1Platinum 1Liver Transplantation 1Irinotecan 1Fluorouracil 1Doxorubicin 1Dexrazoxane 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
PRETEXT I Hepatoblastoma × Sirolimus × Gastrointestinal × Clear all
NCT00980460 2026-05-04

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
236 enrolled 18 charts
Gastrointestinal

PRETEXT I Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡